UnitedHealth Group Inc. (NYSE:UNH) Director Gail R. Wilensky sold 5,460 shares of UnitedHealth Group stock in a transaction dated Thursday, November 17th. The shares were sold at an average price of $150.55, for a total transaction of $822,003.00. Following the sale, the director now owns 60,052 shares of the company’s stock, valued at $9,040,828.60. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink.

UnitedHealth Group Inc. (NYSE:UNH) traded up 0.64% during trading on Monday, hitting $150.41. 3,867,766 shares of the stock were exchanged. UnitedHealth Group Inc. has a one year low of $107.51 and a one year high of $153.96. The company has a market cap of $143.16 billion, a price-to-earnings ratio of 22.22 and a beta of 0.63. The stock’s 50 day moving average is $141.43 and its 200-day moving average is $138.91.

UnitedHealth Group (NYSE:UNH) last released its quarterly earnings data on Tuesday, October 18th. The healthcare conglomerate reported $2.17 EPS for the quarter, topping analysts’ consensus estimates of $2.08 by $0.09. The firm earned $46.30 billion during the quarter, compared to the consensus estimate of $46.09 billion. UnitedHealth Group had a net margin of 3.62% and a return on equity of 19.92%. The firm’s revenue was up 11.6% on a year-over-year basis. During the same quarter in the previous year, the company posted $1.77 earnings per share. On average, equities research analysts expect that UnitedHealth Group Inc. will post $8.01 earnings per share for the current fiscal year.

Insider Buying and Selling by Quarter for UnitedHealth Group (NYSE:UNH)

The firm also recently disclosed a quarterly dividend, which will be paid on Tuesday, December 13th. Shareholders of record on Friday, December 2nd will be issued a $0.625 dividend. This represents a $2.50 dividend on an annualized basis and a yield of 1.66%. The ex-dividend date of this dividend is Wednesday, November 30th. UnitedHealth Group’s dividend payout ratio is presently 36.93%.

UNH has been the subject of a number of research reports. Credit Suisse Group AG restated an “outperform” rating and issued a $160.00 price objective (up previously from $155.00) on shares of UnitedHealth Group in a report on Friday, October 21st. Leerink Swann set a $175.00 price objective on shares of UnitedHealth Group and gave the company a “buy” rating in a report on Wednesday, October 19th. Mizuho lifted their price objective on shares of UnitedHealth Group from $160.00 to $169.00 and gave the company a “buy” rating in a report on Wednesday, October 19th. Vetr cut shares of UnitedHealth Group from a “buy” rating to a “hold” rating and set a $144.66 price objective for the company. in a report on Tuesday, October 18th. Finally, Jefferies Group restated a “buy” rating on shares of UnitedHealth Group in a report on Tuesday, August 23rd. Three investment analysts have rated the stock with a hold rating and twenty-two have issued a buy rating to the stock. The company has an average rating of “Buy” and a consensus price target of $157.11.

A number of institutional investors have recently added to or reduced their stakes in UNH. Park National Corp OH boosted its stake in UnitedHealth Group by 2.4% in the second quarter. Park National Corp OH now owns 9,211 shares of the healthcare conglomerate’s stock worth $1,301,000 after buying an additional 216 shares during the last quarter. Cullinan Associates Inc. boosted its stake in UnitedHealth Group by 9.2% in the second quarter. Cullinan Associates Inc. now owns 29,967 shares of the healthcare conglomerate’s stock worth $4,231,000 after buying an additional 2,517 shares during the last quarter. First Financial Bank N.A. Trust Division boosted its stake in UnitedHealth Group by 0.3% in the second quarter. First Financial Bank N.A. Trust Division now owns 7,847 shares of the healthcare conglomerate’s stock worth $1,108,000 after buying an additional 21 shares during the last quarter. Kistler Tiffany Companies LLC boosted its stake in UnitedHealth Group by 4.3% in the second quarter. Kistler Tiffany Companies LLC now owns 3,617 shares of the healthcare conglomerate’s stock worth $511,000 after buying an additional 149 shares during the last quarter. Finally, Fulton Bank N.A. boosted its stake in UnitedHealth Group by 21.9% in the second quarter. Fulton Bank N.A. now owns 7,005 shares of the healthcare conglomerate’s stock worth $989,000 after buying an additional 1,259 shares during the last quarter. 86.04% of the stock is owned by hedge funds and other institutional investors.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated is a diversified healthcare company. The Company operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight and OptumRx. The Company conducts its operations through two business platforms: health benefits operating under UnitedHealthcare and health services operating under Optum.

5 Day Chart for NYSE:UNH

Receive News & Stock Ratings for UnitedHealth Group Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group Inc. and related stocks with our FREE daily email newsletter.